The European School of Medical Oncology (ESMO) Breast Cancer Virtual Congress 2021 brought together global experts to discuss the latest advances in breast cancer. VJOncology were delighted to interview speakers and get their perspectives on the most exciting updates.

See our top editorial picks below, and more at VJOncology.com.
Paolo Tarantino

Trastuzumab deruxtecan for HER2-low breast cancer
Saverio Alberti

E-cadherin inactivation drives TNBC metastases
Lisa Carey

Decision-making in metastatic HER2+ breast cancer
Elisa Agostinetto

ROSALINE: targeting ROS1 with ET for breast cancer
Ahmad Awada

Abemaciclib for HR+/HER2- advanced or metastatic breast cancer
Rebecca Dent

Treating early-stage TNBC
YouTube
Twitter
LinkedIn